OX40/OX40L interactions in allergen-induced airway inflammation and remodeling

OX40/OX40L 在过敏原诱导的气道炎症和重塑中的相互作用

基本信息

批准号：
8704272
负责人：
TAYLOR A DOHERTY
金额：
$ 13.23万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN DIEGO
依托单位国家：
美国
项目类别：
财政年份：
2010
资助国家：
美国
起止时间：
2010-08-16 至 2015-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8704272
关键词：
Acute Adoptive Transfer Advisory Committees Affect Allergens Antibodies Antigen-Presenting Cells Asthma Biopsy Specimen Blocking Antibodies Bone Marrow California Cells Cellular biology Chimera organism Chronic Coculture Techniques Communication Development Development Plans Environment Epithelial Epithelial Cells Event Family Family member Fellowship Fibrosis Flow Cytometry Gene Expression Growth Factor Human Hypersensitivity Image Immunology In Situ Hybridization In Vitro Individual Inflammation Inflammatory Institutes Internal Medicine Journals Knock-out Laboratories Ligands Lung Lung Inflammation Maintenance Mediating Medicine Memory Mentors Metaplasia Modeling Mucous body substance Mus Myofibroblast Peripheral Physicians Play Prevalence Process Program Development Relative (related person)Research Research Personnel Research Project Grants Residencies Role Sampling Scientist Signal Transduction Smooth Muscle Specimen Structure T-Cell Proliferation T-Lymphocyte TNF gene TNFSF4 gene Testing Time Training Training Programs Training Technics Tumor Necrosis Factor Receptor United States Universities Work airway inflammation airway remodeling angiogenesis asthmatic airway bronchial epithelium career career development cell type cytokine eosinophil in vivo mast cell mouse model muscle form peripheral blood professor response skills therapeutic target tumor necrosis factor ligand superfamily member 4 tumor necrosis factor receptor superfamily member 4

项目摘要

DESCRIPTION (provided by applicant): This proposal describes a 5 year training program for the development of an academic career in laboratory medicine. The principle investigator has completed structured internal medicine residency and allergy/immunology fellowship training at the University of California at San Diego and has been appointed as an Assistant Professor. He will expand upon his scientific skills through a focused career development plan and training in T cell costimulation as applied to chronic allergen-induced airway inflammation and remodeling. Dr. David Broide is a professor of medicine at UC San Diego and will mentor the principle investigator's scientific development. Dr. Broide is a recognized leader in mechanisms of airway inflammation and remodeling and has a strong record of mentoring developing physician scientists. An advisory committee of scientists, including Dr. Michael Croft who has expertise in T cell biology and costimulation, will provide career and project guidance. In addition, related course work, seminars, journal clubs, and specific laboratory technique training will accompany ample protected research time in a supportive academic environment in the Department of Medicine at UCSD. The research project will focus on the role of costimulatory molecules in chronic allergen-induced airway inflammation and remodeling. Dr. Croft's laboratory at La Jolla Institute for Allergy and Immunology has discovered a critical role for the TNFR family member OX40 in acute allergen induced airway inflammation, as well as in TH2 memory responses. The proposed studies will test the critical roles of OX40/OX40 ligand interactions in a chronic allergen-induced murine model of asthma and airway remodeling through knockout, antibody- blocking, adoptive transfer, and imaging studies. Additionally, we will evaluate the role of OX40 on TH2 cells and cross talk with eosinophils and bronchial epithelial cells expressing OX40L. Finally, we will determine the expression of OX40 and OX40L in human asthmatic peribronchial samples and evaluate allergen specific OX40-mediated TH2 responses, including key signaling events, from peripheral blood. These studies have direct significance for understanding the mechanisms of chronic asthma and may reveal therapeutic targets. Importantly, asthma affects 7% of people in the United States and prevalence has increased dramatically over the past few decades.

描述（由申请人提供）：该提案描述了一项为期5年的培训计划，以开发实验室医学的学术生涯。这位主要研究人员已在加利福尼亚大学圣地亚哥分校完成了结构化的内科住院医师和过敏/免疫学奖学金培训，并被任命为助理教授。他将通过一项重点的职业发展计划和T细胞共刺激的培训来扩展他的科学技能，并适用于慢性过敏原引起的气道炎症和改造。 David Broide博士是加州大学圣地亚哥分校的医学教授，并将指导主要研究者的科学发展。 Broide博士是气道炎症和重塑机制的公认领导者，并具有指导发展医师科学家的良好记录。一个科学家咨询委员会，包括在T细胞生物学和共同刺激方面具有专业知识的迈克尔·克罗夫特（Michael Croft）博士，将提供职业和项目指导。此外，相关课程工作，研讨会，期刊俱乐部和特定的实验室技术培训将伴随着UCSD医学系的支持性学术环境中的充足的研究时间。该研究项目将重点介绍共刺激分子在慢性过敏原引起的气道炎症和重塑中的作用。 La Jolla过敏和免疫学研究所的Croft博士实验室发现TNFR家族成员OX40在急性过敏原诱导的气道炎症以及TH2记忆反应中起着至关重要的作用。提出的研究将通过敲除，抗体阻断，收养转移和成像研究来测试OX40/OX40配体相互作用的关键作用。此外，我们将评估OX40在Th2细胞中的作用，并与表达OX40L的嗜酸性粒细胞和支气管上皮细胞进行交流。最后，我们将确定人类哮喘周围样品中OX40和OX40L的表达，并评估过敏原特异性OX40介导的TH2反应，包括关键信号事件，来自外周血。这些研究对于理解慢性哮喘的机制具有直接的意义，并可能揭示了治疗靶标。重要的是，在过去的几十年中，哮喘影响了美国7％的人，并且患病率急剧增加。

项目成果

期刊论文数量（9）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

Allergen challenge in allergic rhinitis rapidly induces increased peripheral blood type 2 innate lymphoid cells that express CD84.

DOI：
10.1016/j.jaci.2013.12.1086
发表时间：
2014-04
期刊：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
影响因子：
14.2
作者：
Doherty, Taylor A.;Scott, David;Walford, Hannah H.;Khorram, Naseem;Lund, Sean;Baum, Rachel;Chang, Jinny;Rosenthal, Peter;Beppu, Andrew;Miller, Marina;Broide, David H.
通讯作者：
Broide, David H.

Impaired induction of allergic lung inflammation by Alternaria alternata mutant MAPK homologue Fus3.